SESSION TITLE: Evaluation and Treatment of ILD
SESSION TYPE: Original Investigation Poster
PRESENTED ON: Wednesday, October 26, 2016 at 01:30 PM - 02:30 PM
PURPOSE: The objectives of this study were to describe patterns of medication use and hospital admissions for patients with sarcoidosis identified in a large commercially insured US population.
METHODS: Data were extracted from the MarketScan® database covering privately insured adults age 18-64 during 2012. Individuals with at least two outpatient records with an ICD-9 diagnosis code of sarcoidosis were selected. All prescription medication, outpatient services and hospital admission records were extracted in addition to demographic variables. Summary measures of filled prescriptions and hospital use were constructed. Use of prednisone, methotrexate, azathioprine, infliximab, adalimumab, golimumab, and hydroxychloroquine were examined, as well number of hospital admissions and total days in the hospital observed during 2012.